Dose Effect of Whey Protein on Gut Hormone Responses in Pre-Diabetics and Type 2 Diabetics by Irvine, Christopher et al.
 
International Journal of Exercise Science                                                             www.tacsm.org 
TACSM Abstract  
 
Dose Effect of Whey Protein on Gut Hormone Responses in Pre-Diabetics 
and Type 2 Diabetics 
 
CHRISTOPHER IRVINE1, TODD CASTLEBERRY1, MICHAEL OLDHAM1, MATTHEW 
BRISEBOIS1, SARAH E. DEEMER2, RYAN GORDON1, AUBRIEN HENDERSON1, and 
VIC BEN-EZRA1 
 
1 Exercise Biochemistry Lab; Kinesiology; Texas Woman’s University; Denton, TX 





Advisor / Mentor: Ben-Ezra, Vic (VBenEzra@twu.edu) 
 
ABSTRACT 
GLP-1 and GIP have been shown to increase following a 50 g dose of whey protein prior to a 
high glycemic load in type 2 diabetics. However, this increase is reduced in diabetics compared 
to healthy individuals. Pancreatic polypeptide (PP) and peptide tyrosine tyrosine (PYY) also 
increase, while ghrelin decreases after the consumption of whey protein; however, it is not 
known if a similar hormone response occurs with a lower dose of whey protein prior to a 
glycemic load or if there is a dose effect. Our hypothesis was that 20 g and 30 g of whey protein 
would increase GLP-1, GIP, PP, and PYY and decrease ghrelin in a dose dependent manner. 
PURPOSE: The purpose of this study was to examine the effect of two different doses of whey 
protein ingested 30 min prior to a 50 g OGTT on gut hormone and incretin response. 
METHODS: Nine diabetic and pre-diabetic participants (n=9, mean ± SD; age: 64.3 + 8.1 yrs.; 
BMI: 29.4 + 6.0 kg/m2; HbA1c: 6.4 + 0.6%) completed three trials. The randomly assigned trials 
consisted of: ingestion of 250ml of water (CON); 250 ml of water + 20 g whey (20g); 250ml of 
water + 30 g whey (30g), prior to completing a 50 g OGTT. Blood was collected at -30, 0, 15, 30, 
60, 90, 120, and 150 min for the measurement of GIP, GLP-1, ghrelin, PP, and PYY. The whey 
protein was administered immediately following the -30 min and the 50 g OGTT began 
immediately after the 0 min blood draw. Metabolites were measured using multiplex fluorescent 
detection. One-way repeated measure ANOVA was used for statistical analysis for each 
dependent variable (P < 0.05). RESULTS: 20g and 30g of whey protein significantly increased 
incremental area under the curve (AUC) of GIP 32% and 38% compared to CON. 30g 
significantly decreased ghrelin AUC -13.9% and -20% compared to 20g and CON. 30g 
significantly increased PP AUC 28% compared to CON only. There were no differences in 
ghrelin and PP AUC between 20g and CON. There were no significant differences for GLP-1 and 
PYY between all trials. CONCLUSION: 30 g of whey protein prior to a glucose challenge 
increased secretion of GIP and PP and decreased ghrelin in type 2 and pre-diabetics. There seems 
to be a dose effect relationship between whey, ghrelin, and PP. 30 g of whey preload may induce 
insulinotropic and satiety effects from GIP, PP, and ghrelin responses in type 2 and pre-diabetics.  
